wing of an acute care hospital, an intermediate care facility for individuals with intellectual disabilities, or a residential treatment facility, disaggregated by each diagnosis described in subparagraph (A) and type of facility, to the extent such information is available. (I) The number and percentage of individuals who are enrolled under the State plan under this title or the State child health plan under title XXI (or under a waiver of such plans) and received an assessment for a mental health condition. (J) The number and percentage of individuals who are enrolled under the State plan under this title or the State child health plan under title XXI (or under a waiver of such plans) and received an assessment for a substance use disorder. (K) The number of mental health services provided to individuals enrolled under the State plan under this title or the State child health plan under title XXI (or under a waiver of such plans) who received an assessment described in subparagraph (I) in the 30 days post-assessment. (L) The number of substance use disorder treatment services provided to individuals enrolled under the State plan under this title or the State child health plan under title XXI (or under a waiver of such plans) who received an assessment described in subparagraph (J) in the 30 days post-assessment. (M) Prescription National Drug Code codes, fill dates, and number of days supply of any covered outpatient drug (as defined in section 1927(k)(2)) that was dispensed to an individual enrolled under the State plan under this title or the State child health plan under title XXI (or under a waiver of such plans) with an episode described in subparagraph (G) or (H) during any period that occurs after the individual’s discharge date defined in subparagraph (G) or (H) (as applicable), and before the admission date applicable under subparagraph (G) or the date of the emergency department visit applicable under subparagraph (H) that were— (i) to treat a mental health condition